1. CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I. Issue 1 (December 2018) Authors: Zabaleta, Nerea; Barberia, Miren; Martin-Higueras, Cristina; Zapata-Linares, Natalia; Betancor, Isabel; Rodriguez, Saray; Martinez-Turrillas, Rebeca; Torella, Laura; Vales, Africa; Olagüe, Cristina; Vilas-Zornoza, Amaia; Castro-Labrador, Laura; Lara-Astiaso, David; Prosper, Felipe; Salido, Eduard... Journal: Nature communications Issue: Volume 9:Issue 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗